Executive Director, Worldwide Operations Office - Pharmacovigilance

Responsibilities

• Serve as the single point of accountability for the global-to-local pharmacovigilance (PV) model, ensuring consistency and compliance across all regions.
• Provide functional oversight of the Worldwide Operations Office (WWOO) and regional PV Hubs to ensure operational performance and quality standards.
• Define the scope and governance of regional PV Hubs, establishing clear boundaries between global, regional, and local responsibilities.
• Establish a governance framework for local process adaptation to meet regional regulatory requirements.
• Partner with cross-functional US and International teams to embed a patient safety mindset across global operations.
• Develop innovative approaches to core activities by integrating new technologies, including AI.
• Aggregate regional insights and risks to shape and prioritize objectives for the PV system.
• Build, coach, and scale a high-performing team while driving succession planning and talent development.

Requirements

• Bachelor's degree required.
• 17+ years of experience in pharmacovigilance and international operations within the life sciences industry.
• Minimum of 7 years in leadership roles with experience managing international or multi-regional operations.
• Strong background in PV compliance, inspection readiness, and quality oversight across multiple markets.
• Proven ability to influence key decision-making with senior stakeholders and cross-functional leaders (e.g., QPPV, Medical Affairs, Regulatory).
• Strategic mindset with the ability to translate regional complexity into clear governance and executive-level insights.

Preferred Qualifications

• Advanced degree (PharmD, MD, MS, or MBA) in life sciences, healthcare, or a related field.
• Experience working with AI technologies in a pharmacovigilance context.

About the Company

Regeneron is a leading biotechnology company that invents life-transforming medicines for people with serious diseases. Founded and led by physician-scientists, the company focuses on translating science into medicine to treat eye diseases, cancer, cardiovascular diseases, and more. Regeneron is recognized for its culture of innovation and commitment to patient-centered care.